Location · Flowood, MS
Clinical trials in Flowood, MS
32 recruiting studies have a site in Flowood, and 0 of them accept healthy volunteers.
32 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Flowood, MS + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Sanofi
- Location
- Flowood, MS + 1 other US site
- Eligibility basics
- Ages 12+ · Men only
- RecruitingPhase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Flowood, MS + 43 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 3
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bristol-Myers Squibb
- Location
- Flowood, MS + 39 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Pfizer
- Location
- Flowood, MS + 26 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva GmbH
- Location
- Flowood, MS + 6 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
CSL Behring
- Location
- Flowood, MS + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Randomized Withdrawal Study in Patients With Schizophrenia
Vanda Pharmaceuticals
- Location
- Flowood, MS + 21 other US sites
- Eligibility basics
- Ages 18–65